000 | 01104 a2200289 4500 | ||
---|---|---|---|
005 | 20250515032228.0 | ||
264 | 0 | _c20060928 | |
008 | 200609s 0 0 eng d | ||
022 | _a1524-9557 | ||
024 | 7 |
_a10.1097/01.cji.0000211301.75374.f9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeslop, Helen E | |
245 | 0 | 0 |
_aCommentary on journal of immunotherapy paper by melenhorst et al. _h[electronic resource] |
260 |
_bJournal of immunotherapy (Hagerstown, Md. : 1997) _c |
||
300 |
_a365-6 p. _bdigital |
||
500 | _aPublication Type: Comment; Journal Article | ||
650 | 0 | 4 | _aAntigen Presentation |
650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 |
_aPhosphoproteins _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aViral Matrix Proteins _ximmunology |
773 | 0 |
_tJournal of immunotherapy (Hagerstown, Md. : 1997) _gvol. 29 _gno. 4 _gp. 365-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.cji.0000211301.75374.f9 _zAvailable from publisher's website |
999 |
_c16392624 _d16392624 |